| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,171 |
7,990 |
$534K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,261 |
6,093 |
$295K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,490 |
6,314 |
$252K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
4,856 |
1,304 |
$200K |
| 99233 |
Prolong inpt eval add15 m |
3,594 |
891 |
$195K |
| 99215 |
Prolong outpt/office vis |
2,171 |
2,105 |
$161K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,626 |
1,616 |
$150K |
| 99205 |
Prolong outpt/office vis |
1,271 |
1,262 |
$136K |
| 95886 |
|
2,147 |
1,175 |
$126K |
| 95911 |
|
970 |
961 |
$122K |
| 99223 |
Prolong inpt eval add15 m |
920 |
829 |
$98K |
| 99222 |
Initial hospital care, per day, moderate complexity |
712 |
669 |
$54K |
| 20611 |
|
1,282 |
1,122 |
$53K |
| 20553 |
|
1,667 |
1,618 |
$45K |
| 80305 |
|
4,995 |
4,882 |
$39K |
| 99407 |
|
2,155 |
2,064 |
$30K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
14 |
14 |
$21K |
| 72114 |
|
399 |
394 |
$14K |
| 93922 |
|
320 |
314 |
$14K |
| 72110 |
|
454 |
450 |
$13K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
212 |
210 |
$13K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
3,279 |
3,100 |
$12K |
| 72052 |
|
184 |
179 |
$7K |
| 72100 |
|
302 |
302 |
$6K |
| 99255 |
|
58 |
57 |
$6K |
| 99253 |
|
86 |
84 |
$5K |
| 99406 |
|
541 |
521 |
$4K |
| 20610 |
|
144 |
119 |
$4K |
| 72050 |
|
134 |
131 |
$4K |
| 99254 |
|
41 |
38 |
$4K |
| 73030 |
|
161 |
142 |
$4K |
| 99442 |
|
249 |
245 |
$3K |
| 99443 |
|
123 |
119 |
$3K |
| 72040 |
|
93 |
93 |
$2K |
| 95910 |
|
15 |
15 |
$1K |
| 73560 |
|
66 |
53 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
89 |
87 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
16 |
16 |
$579.36 |
| 73562 |
|
15 |
15 |
$518.76 |
| 73502 |
|
15 |
12 |
$453.89 |
| 99484 |
|
16 |
16 |
$402.56 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
435 |
424 |
$373.93 |
| 76942 |
|
13 |
13 |
$343.48 |
| 81003 |
|
76 |
76 |
$115.49 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,387 |
1,270 |
$99.32 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
48 |
48 |
$56.52 |
| 3074F |
|
4,768 |
4,655 |
$0.59 |
| 3078F |
|
3,688 |
3,626 |
$0.42 |
| 3079F |
|
2,476 |
2,444 |
$0.29 |
| 3077F |
|
2,114 |
2,080 |
$0.28 |
| 3080F |
|
2,203 |
2,159 |
$0.28 |
| 3075F |
|
1,515 |
1,497 |
$0.13 |
| 1159F |
|
495 |
468 |
$0.03 |
| 1160F |
|
466 |
441 |
$0.03 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
117 |
114 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
72 |
71 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
54 |
54 |
$0.00 |
| G8432 |
Depression screening not documented, reason not given |
4,088 |
3,994 |
$0.00 |
| 99024 |
|
1,236 |
1,185 |
$0.00 |
| 94760 |
|
704 |
664 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
202 |
200 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
154 |
152 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
399 |
375 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
100 |
98 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
50 |
48 |
$0.00 |